Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIGHT-1
- Development stage
- Unknown
- Lead developer
- MediPrint Ophthalmics
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
01
Overview
SIGHT-1 is a 3D-printed, drug-eluting contact lens developed by MediPrint Ophthalmics for the treatment of glaucoma and ocular hypertension. The system is designed to provide sustained, continuous release of bimatoprost, a prostaglandin analog, to the ocular surface over a period of several days. By integrating the drug into a contact lens using proprietary MediPrint technology, the product aims to overcome the limitations of traditional eye drops, such as poor patient compliance and significant fluctuations in intraocular pressure. SIGHT-1 is currently in Phase 1/2 clinical development and represents a novel approach to ocular drug delivery by combining a medical device with a established pharmaceutical agent.
- Other names
- LLT-BMT1LLT-BMT-1LLT-BMT 1
02
Targets
Prostanoid R (Prostanoid receptors)
Beyond the preview
Go deeper on SIGHT-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIGHT-1.